Chimerix Inc (NASDAQ:CMRX)

10.61
Delayed Data
As of 3:59pm ET
 +0.65 / +6.53%
Today’s Change
1.19
Today|||52-Week Range
11.57
+119.67%
Year-to-Date
Chimerix (CMRX) Q4 2020 Earnings Call Transcript
Feb 25 / MotleyFool.com - Paid Partner Content
Steven Cohen Dives Into Chimerix
Feb 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close9.96
Today’s open10.02
Day’s range9.94 - 10.73
Volume27,324
Average volume (3 months)919,426
Market cap$842.2M
Data as of 3:59pm ET, 03/02/2021

Growth & Valuation

Earnings growth (last year)+65.49%
Earnings growth (this year)-2.38%
Earnings growth (next 5 years)--
Revenue growth (last year)-57.09%
P/E ratioNM
Price/Sales55.91
Price/Book8.42

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...-0.08-0.46%
PRVBProvention Bio Inc-0.55-4.28%
----
AERIAerie Pharmaceutical...+0.61+3.18%
Data as of 4:00pm ET, 03/02/2021

Financials

Next reporting dateMay 10, 2021
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$5.4M
Annual profit (last year)-$43.5M
Net profit margin-810.16%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Durham, North Carolina

Forecasts